1. |
- Bassyouni, Fatma A., et al.
(författare)
-
Synthesis, pharmacological activity evaluation and molecular modeling of new polynuclear heterocyclic compounds containing benzimidazole derivatives
- 2012
-
Ingår i: Archives of pharmacal research. - : Springer Science and Business Media LLC. - 0253-6269 .- 1976-3786. ; 35:12, s. 2063-2075
-
Tidskriftsartikel (refereegranskat)abstract
- Novel heterocyclic compounds containing benzimidazole derivatives were synthesized from 2-(1Hbenzimidazol-2-yl) acetonitrile (1) and arylhydrazononitrile derivative 2 was obtained via coupling of 1 with 4-methyl phenyldiazonium salt, which was then reacted with hydroxylamine hydrochloride to give amidooxime derivative 3. This product was cyclized into the corresponding oxadiazole derivative 4 upon reflux in acetic anhydride. Compound 4 was refluxed in DMF in the presence of triethylamine to give the corresponding 5-(1H-benzimidazol-2-yl)-2-p-tolyl-2H-1,2,3-triazol-4-amine 6. Treatment of compound 6 with ethyl chloroformate afforded 2,6-dihydro-2-(4-methylphenyl)-1,2,3-triazolo[4aEuro(3),5aEuro(3)-4',5']pyrimido[1,6-a]benzimidazole-5(4H)-one (8). 1,2-bis(2-cyanomethyl-1H-benzimidazol-1-yl)ethane-1,2-dione (10) was synthesized via the condensation reaction of 2-(1H-benzimidazol-2-yl) acetonitrile (1) and diethyloxalate. The reactivity of compound 10 towards some diamine reagents was studied. The in vitro antimicrobial activity of the synthesized compounds was investigated against several pathogenic bacterial strains such as Escherichia coli O157, Salmonella typhimurium, E. coli O119, S. paratyphi, Pseudomonas aeruginosa, Staphylococcus aureus, Listeria monocytogenes and Bacillus cereus. The results of MIC revealed that compounds 12a-c showed the most effective antimicrobial activity against tested strains. On the other hand, compounds 12a, b exhibited high activity against rotavirus Wa strain while compounds 12b, c exhibited high activity against adenovirus type 7. In silico target prediction, docking and validation of the compounds 12a-c were performed. The dialkylglycine decarboxylase bacterial enzyme was predicted as a potential bacterial target receptor using pharmacophorebased correspondence with previous leads; giving the highest normalized scores and a high correlation docking score with mean inhibition concentrations. A novel binding mechanism was predicted after docking using the MOE software and its validation.
|
|
2. |
- Bassyouni, Fatma, et al.
(författare)
-
Synthesis and Antiviral Investigation of New Polynuclear Heterocyclic Compounds Containing Tetrahydroindazole Derivatives
- 2016
-
Ingår i: Research Journal of Pharmaceutical, Biological and Chemical Sciences. - 0975-8585. ; 7:6, s. 24-37
-
Tidskriftsartikel (refereegranskat)abstract
- The antiviral materials or compounds required for the treatment of viruses cause some infectious diseases such as Coxsackievirus B4 (CVB4), rotavirus Wa strain, and adenovirus type 7 are indispensable and of great necessity. The aim of the present study was to synthesize a new series of substituted indazole derivatives obtained from 2-(4-substituted-benzylidene)-4-phenylcyclohexanones and 2,6-bis (4-substituted-benzylidene)-4-phenylcyclohexanone derivatives. The products formed were reacted with 4-hydrazinylbenzoic acid or 2hydrazino- 6-methylbenzothiazole in the presence of cuprous oxide and Cs2CO3 as catalysts to give rise to a variety of indazole derivatives in a simple experimental procedure in good yields and short reaction time. The new compounds were fully characterized by spectroscopic and analytical methods. The synthesized compounds were evaluated for their antiviral activity against Coxsackievirus B4, adenovirus type 7 and rotavirus Wa strain. The bioassay results showed that the synthesized compounds possessed variable antiviral bioactivity. Compound (3-Fluoro-7-(fluoromethylene)-4,5,6,7-tetrahydro-2-(6-methylbenzo[d] thiazol-2-yl)-5phenyl-2H-indazole (24) exhibited moderate activity against both Coxsackievirus B4 and rotavius Wa strain and potentially promising activity against adenovirus type 7. On the other hand, 3-Chloro-7(chloromethylene)-4,5,6,7-tetrahydro-2-(6-methylbenzo[d] thiazol-2-yl)-5-phenyl-2H-indazole (25) and 7-(2,6-Dimethoxybenzylidene)-4,5,6,7-tetrahydro-3-(2,6-dimethoxyphenyl)-2-(6-methylbenzo[d]thiazol-2-yl)-5phenyl-2H-indazole (26) revealed potential promising activity against adenovirus type 7, while compounds 25 and 26 revealed promising activities against rotavirus Wa strain.
|
|